Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is more common in men aged 18-49 and increases with age.

Hair restoration surgery has evolved over time, with a focus on natural-looking results and managing patient expectations, while also considering potential complications and the lifelong progression of male pattern baldness.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Scalp micropigmentation, a cosmetic tattoo technique, is a promising non-surgical treatment for hair and scalp deformities, despite potential complications.

Early hair loss may indicate prostate issues.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Proper education can prevent traction alopecia in women of color.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Platelet-rich plasma (PRP) injections effectively treat hair loss and thinning in both men and women, with high satisfaction and no major side effects.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.